Boston Scientific (BSX - Get Report) shares were in focus Wednesday after the medical device manufacturer reported third quarter results that were in line with analysts expectations. The company reported earnings of $0.27 a share, in line with expectations. Revenue of $2.11 billion, surpassed Wall Street's expectations of $2.07 billion